TEVA Stock Rises 72.5% This Year: Time to Buy, Sell or Hold?
Teva's reasonable valuation, an improving pipeline and the prospect of growth in sales and profits are good enough reasons for those who own the stock to stay invested.
| Ticker |
Sentiment |
Impact |
|
ALVO
|
Neutral
|
4 %
|
|
RPRX
|
Neutral
|
4 %
|
|
TEVA
|
Somewhat Bullish
|
17 %
|
|
SNY
|
Neutral
|
12 %
|
